DE69923698D1 - Verwendung von 3-(1h-imidazol-4-ylmethyl)-indan-5-ol zur herstellung eines medikamentes zur intraspinalen, intrathekalen und epiduralen anwendung - Google Patents

Verwendung von 3-(1h-imidazol-4-ylmethyl)-indan-5-ol zur herstellung eines medikamentes zur intraspinalen, intrathekalen und epiduralen anwendung

Info

Publication number
DE69923698D1
DE69923698D1 DE69923698T DE69923698T DE69923698D1 DE 69923698 D1 DE69923698 D1 DE 69923698D1 DE 69923698 T DE69923698 T DE 69923698T DE 69923698 T DE69923698 T DE 69923698T DE 69923698 D1 DE69923698 D1 DE 69923698D1
Authority
DE
Germany
Prior art keywords
indan
ylmethyl
intratheal
intraspinal
imidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69923698T
Other languages
English (en)
Other versions
DE69923698T2 (de
Inventor
Antti Haapalinna
Jyrki Lehtimaeki
Tiina Leino
Timo Viitamaa
Raimo Virtanen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Oyj filed Critical Orion Oyj
Application granted granted Critical
Publication of DE69923698D1 publication Critical patent/DE69923698D1/de
Publication of DE69923698T2 publication Critical patent/DE69923698T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
DE69923698T 1998-09-28 1999-09-27 Verwendung von 3-(1h-imidazol-4-ylmethyl)-indan-5-ol zur herstellung eines medikamentes zur intraspinalen, intrathekalen und epiduralen anwendung Expired - Lifetime DE69923698T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10198698P 1998-09-28 1998-09-28
US101986P 1998-09-28
PCT/FI1999/000793 WO2000018400A1 (en) 1998-09-28 1999-09-27 Use of 3-(1h-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration

Publications (2)

Publication Number Publication Date
DE69923698D1 true DE69923698D1 (de) 2005-03-17
DE69923698T2 DE69923698T2 (de) 2006-01-12

Family

ID=22287519

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69923698T Expired - Lifetime DE69923698T2 (de) 1998-09-28 1999-09-27 Verwendung von 3-(1h-imidazol-4-ylmethyl)-indan-5-ol zur herstellung eines medikamentes zur intraspinalen, intrathekalen und epiduralen anwendung

Country Status (24)

Country Link
US (1) US6495584B1 (de)
EP (1) EP1117399B1 (de)
JP (1) JP4647785B2 (de)
KR (1) KR100646811B1 (de)
CN (1) CN1320034A (de)
AT (1) ATE288753T1 (de)
AU (1) AU756104B2 (de)
BG (1) BG105469A (de)
CA (1) CA2345521C (de)
CZ (1) CZ299918B6 (de)
DE (1) DE69923698T2 (de)
DK (1) DK1117399T3 (de)
EA (1) EA003216B1 (de)
EE (1) EE200100193A (de)
ES (1) ES2237205T3 (de)
HK (1) HK1039751A1 (de)
HU (1) HU227634B1 (de)
IL (2) IL141680A0 (de)
NO (1) NO330436B1 (de)
NZ (1) NZ510233A (de)
PL (1) PL346908A1 (de)
SK (1) SK3812001A3 (de)
UA (1) UA61152C2 (de)
WO (1) WO2000018400A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1196168A2 (de) * 1999-06-25 2002-04-17 Orion Corporation Verfahren zur verabreichung eines imidazolderivats um analgesie zu erhalten
FI20022159A0 (fi) 2002-12-05 2002-12-05 Orion Corp Uusia farmaseuttisia yhdisteitä

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI894911A0 (fi) * 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
US5801188A (en) * 1997-01-08 1998-09-01 Medtronic Inc. Clonidine therapy enhancement

Also Published As

Publication number Publication date
IL141680A (en) 2007-06-17
EA003216B1 (ru) 2003-02-27
IL141680A0 (en) 2002-03-10
US6495584B1 (en) 2002-12-17
HUP0103864A3 (en) 2002-08-28
EE200100193A (et) 2002-08-15
NO20011545D0 (no) 2001-03-26
KR20010079860A (ko) 2001-08-22
CZ2001933A3 (cs) 2001-08-15
WO2000018400A1 (en) 2000-04-06
HK1039751A1 (zh) 2002-05-10
CA2345521A1 (en) 2000-04-06
BG105469A (en) 2001-11-30
NO330436B1 (no) 2011-04-11
CZ299918B6 (cs) 2008-12-29
HUP0103864A2 (hu) 2002-05-29
PL346908A1 (en) 2002-03-11
AU5986099A (en) 2000-04-17
CA2345521C (en) 2009-05-05
NZ510233A (en) 2003-05-30
ATE288753T1 (de) 2005-02-15
JP4647785B2 (ja) 2011-03-09
DE69923698T2 (de) 2006-01-12
AU756104B2 (en) 2003-01-02
UA61152C2 (en) 2003-11-17
KR100646811B1 (ko) 2006-11-17
NO20011545L (no) 2001-03-26
CN1320034A (zh) 2001-10-31
ES2237205T3 (es) 2005-07-16
EA200100405A1 (ru) 2001-10-22
JP2002525324A (ja) 2002-08-13
HU227634B1 (en) 2011-10-28
EP1117399A1 (de) 2001-07-25
SK3812001A3 (en) 2002-02-05
DK1117399T3 (da) 2005-03-29
EP1117399B1 (de) 2005-02-09

Similar Documents

Publication Publication Date Title
EA200400589A1 (ru) Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения
ATE506059T1 (de) Therapie zur behandlung der überaktiven blase
BR0214967A (pt) Composto, sal famaceuticamente aceitável, processo para a preparação de um composto, composição farmacêutica, uso de um composto e método de tratar um distúrbio de um paciente
ES2295609T3 (es) Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor.
TNSN04246A1 (fr) Derives d'heteroarylamides benzocondenses de thienopyridines utiles comme agents therapeutiques, compositions pharmaceutiques les contenant et methodes pour leur utilisation
JP4675103B2 (ja) 脳機能を改善する医薬組成物および脳機能を改善するための方法
BRPI0406883A (pt) Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
DE60218193D1 (de) Verwendung von 2-oxo-1-pyrrolidin-derivaten zur herstellung eines arzneimittels zur behandlung von dyskinesia
ATE279192T1 (de) Die verwendung eines benzimidazoles zur herstellung eines medikamentes zur krebsvorbeugung
ATE225177T1 (de) Verwendung von (+)mefloquine zur behandlung von malaria
DE60123117D1 (de) Verwendung von alpha-halogenacryloyl-distamycin derivaten zur herstellung eines medikaments zur behandlung von krebs
ATE415965T1 (de) Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung
DE69923698D1 (de) Verwendung von 3-(1h-imidazol-4-ylmethyl)-indan-5-ol zur herstellung eines medikamentes zur intraspinalen, intrathekalen und epiduralen anwendung
MXPA05008711A (es) Uso de r-10-hidroxi-10,11-dihidro-carbamazepina en dolor neuropatico.
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
PT1082116E (pt) Utilizacao de derivados de 4-piperidinometanol no tratamento de desordens do neurodesenvolvimento
EP1632235A3 (de) Verwendung von hochselektiven Norepinephrin-Aufnahme-Inhibitoren zur Behandlung von mentalen Erkrankungen
Rorarius et al. The effect of diclofenac and ketoprofen on halothane MAC in rabbit
DE69910242D1 (de) Verwendung eines Nikotin-Rezeptor Agonisten zur Herstellung eines Medikaments zur Behandlung von Zwangsneurosen
MXPA02007454A (es) Compuestos utiles para tratamiento o prevencion de una enfermedad mediada por el alfa-2b-adrenoceptor.
ATE345124T1 (de) Verwendung von l-acetylcarnitin zur herstellung eines medikaments zur behandlung von anhedonia
CA2543986A1 (en) Norepinephrine reuptake inhibitors and methods of using the same

Legal Events

Date Code Title Description
8364 No opposition during term of opposition